The U.S. Food and Drug Administration (FDA) advised doctors on Thursday to stop using power morcellators in laparoscopic uterine fibroid removal surgeries because of cancer concerns. The agency said the surgical technique could unexpectedly spread cancerous tissue into a patient’s stomach.
The FDA recommended that doctors look into other treatment methods for symptomatic fibroids rather than using the tool to remove fibroids or a woman’s uterus laparoscopically, according to Law360. Despite the severity of the risks, the agency didn’t remove the nearly two-dozen power morcellators from the market. More Uterine Fibroid Procedure May Cause Cancer, FDA Warns